Page 82 - Genentech News Today

By Colin Kellaher Kronos Bio is shedding about 19% of its staff as the clinical-stage biopharmaceutical moves to extend its cash runway following positive...

With Jeli, the PagerDuty Operations Cloud improves enterprise resilience, reduces the impact and risk of operational failure, and lessens the need for costly point solutions ...

Operator: Hello and welcome to the BioMarin Pharmaceutical Third Quarter 2023 Conference Call. All lines have been placed on meet to prevent any background noise.

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it will report its third quarter 2023...

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to provide a preliminary update...

The United States Court of Appeals for the Federal Circuit recently delivered a precedential opinion in Baxalta v. Genentech, affirming the invalidity of patent claims directed to a genus of antibodies...

- Total Revenues of $471.9 million, Cabozantinib Franchise U.S. Net Product Revenues of $426.5 million - - Conference Call and Webcast Today at 5:00 PM Eastern Time - ...

/PRNewswire/ -- DelveInsights Spinal Cord Injury Market Insights report includes a comprehensive understanding of current treatment practices, spinal cord...

MAINZ, Germany, October 31, 2023 - BioNTech SE will present data updates across multiple immuno-oncology programs at the Society for Immunotherapy of Cancers 38th Annual Meeting in...

Pat Lamoureux lives with her husband, Roger, in a home on the edge of Sisters Country. Theyve created a beautiful place with trees turning brilliant